Cargando…
T-Lymphocytes Activated by Dendritic Cells Loaded by Tumor-Derived Vesicles Decrease Viability of Melanoma Cells In Vitro
Immunotherapy represents an innovative approach to cancer treatment, based on activating the body’s own immune system to combat tumor cells. Among various immunotherapy strategies, dendritic cell vaccines hold a special place due to their ability to activate T-lymphocytes, key players in cellular im...
Autores principales: | Filin, Ivan Yurevich, Mayasin, Yuriy Pavlovich, Kharisova, Chulpan Bulatovna, Gorodilova, Anna Valerevna, Chulpanova, Daria Sergeevna, Kitaeva, Kristina Viktorovna, Rizvanov, Albert Anatolyevich, Solovyeva, Valeria Vladimirovna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605065/ https://www.ncbi.nlm.nih.gov/pubmed/37886937 http://dx.doi.org/10.3390/cimb45100493 |
Ejemplares similares
-
The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment
por: Gorodilova, Anna Valerevna, et al.
Publicado: (2023) -
Cell Immunotherapy against Melanoma: Clinical Trials Review
por: Filin, Ivan Y., et al.
Publicado: (2023) -
Analysis of the Interaction of Human Neuroblastoma Cell-Derived Cytochalasin B Induced Membrane Vesicles with Mesenchymal Stem Cells Using Imaging Flow Cytometry
por: Solovyeva, Valeriya V., et al.
Publicado: (2022) -
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
por: Filin, Ivan Y., et al.
Publicado: (2021) -
Characteristics and Resistance to Cisplatin of Human Neuroblastoma Cells Co-Cultivated with Immune and Stromal Cells
por: Kitaeva, Kristina V., et al.
Publicado: (2022)